China may be a juggernaut that’s cooled its jets a little of late (purposefully I might add) but the massive potential for a well-managed Chinese company constantly has me on the lookout for more.

So after a little homework it’ll come as no surprise that we’ve added a bunch of Hutchison China Meditech to our portfolio – 520 shares to be exact, that were purchased for £3.14 a pop on 19th July 2010.

The crux of the buy: Anyone who’s picked up a newspaper in the past decade knows that times in China, they are a changin’. China’s move from a predominantly agrarian economy to a 21st century economic super-power brings with it certain knock on effects. Health-care reform is now firmly in the sights of Party leaders and that’s where Hutchison China Meditech step in.

Chinese authorities have recently released a list of 307 primary medicines that state-owned health-care centres must stock by 2020. Hutchison China Meditech produces 17 of these, 16 of these are generic (predominantly over-the-counter and prescription traditional Chinese medicines) but one – SXBX, patented until 2016 – is not. This alone is more than justification for a little investor excitement.

Hutchison China Meditech also has its finger in a couple of other pies: it owns one of China’s largest pharma R&D businesses which in all likelihood, will be floated on Nasdaq in the next couple of years. HCM.L is also involved in an organic foods joint venture which has the potential to become a very significant contributor to profits in the coming years.

As always do your own homework, the Hutchison China Meditech website is a good place to start. Thanks again for dropping by.

Entertainment One is a leading independent entertainment group, with diversified operations incorporating film, television and music across five territories (UK, Canada, US, Holland, Belgium).

We liked what we’d heard so we did a little follow up homework and when Small Company Share Watch (our fave Small Cap tip sheet) went and ran a feature extolling the potential of ETO.L, we just had to take the plunge.

That was in May 2010, the price was 61 pence and there was very strong talk of a move from AIM to London Stock Exchange’s main market.

Fast forward to mid July 2010, two short months later and ETO.L is trading in the range of 77 to 81 pence (though if you were inclined to sell today you may find yourself being offered closer to the latter).

Following on from a couple of shareholder meetings in June, last Friday (9 July 2010), Entertainment One released the following:

Entertainment One Ltd. (“the Company”) is pleased to announce that it has received a final Cayman Court Order sanctioning the scheme of arrangement previously approved by shareholders at a meeting held on 28 June 2010.

The scheme of arrangement is expected to become effective at 5pm BST on 14 July 2010, following which the place of incorporation of the ultimate parent holding company of the Entertainment One group of companies will change from the Cayman Islands to Canada, and all of the ordinary shares of the Company will be exchanged for an equal amount of common shares of Entertainment One Ltd., a newly incorporated Canadian company (“Entertainment One Canada”).

Following the scheme becoming effective, it is expected that at 8am BST on 15 July 2010 the common shares of Entertainment One Canada will be admitted to the Official List and to trading on the London Stock Exchange’s main market for listed securities.

In short, ETO.L has changed names and is off to play with the big boys on the main board.

Ceteris paribus, this should have the effect of creating a little buzz around Entertainment One as it gets a squirt of media coverage and plonks itself on the radar of institutional buyers. Time will tell.

As it stands now we’ve gained 25% on ETO.L in the two months leading up to Friday’s announcement, so anything from here is gravy.

We liked what we saw when we jumped into ETO.L in May and we’re not going anywhere soon. But in a market that’s swinging and swaying like this one, it’s nice to know that you can still make a buck on a speuclative move to the main board.

Thanks again for dropping by and remember over the year’s this has been nothing more than a poorly paying hobby for me. My ranting should never be taken as investment advice, go seek out the professionals for that and always do a ton of homework.

After purchasing our initial tranche of 1,960 China Biodiesel shares back in July 2009 for 6.6 pence a share and topping up a short week later at 10.06 pence (yep that’s a 50% rise in that short week), we were averaged into CBI.L at 9.29 pence a share. And whilst the share price did go on to test 20 pence in August 2009, since then there’s been a lot of market apathy – time spent between 8 and 14 pence. Lately it’s split the middle of those highs and lows and has camped out around the 11 pence mark and to be honest unless there was some big news coming fast, the way things are, I expected nothing but a gradual slide from CBI.L over the coming months.

Here’s a few of the reasons we jumped on board with China Biodiesel in the first place. Though I may dress it up a little, my justification was almost purely chartist at the time. It’s hard for the risk craving (it’s almost a sickness) to watch a penny share go from 2 pence to 6 and not want to have a little taste of that action.

Anyway, back to the tender offer. It came in at 16.5 pence. And when all is said and done and everyone is paid up, China Biodiesel will be ditching its AIM listing. Here’s a little of the reasoning behind the decision:

The share price performance of the Company has recently been disappointing and a source of frustration for the Board. The Directors believe that the development of the business and its growth potential has not been adequately reflected in the value attributed by the public market to the Ordinary Shares. The Directors believe that the reasons for this under-valuation are multiple and complex, but principally include a lack of liquidity (common to many small cap companies) impacted by the structure of the Company’s share register and also a lack of interest in Chinese small cap companies.

So as the sun comes down on China Biodiesel we’ve cleared 7.21 pence a share on our 8,792 shares to stand roughly £634 to the good before costs on our £817 initial investment. All that  in a little less than 12 months. Nothing corny about that!

Following a nudge from an Investor Trader reader a few months back now, we’ve been keeping an eye on Entertainment One (ETO.L). After Small Company Sharewatch (our absolute fave small cap tip sheet) featured them in their May 2010 edition, we decided is was time to take an even closer look.

Entertainment One is a leading independent entertainment group, with diversified operations incorporating film, television and music across five territories (UK, Canada, US, Holland, Belgium)

On the film side of things (which it is estimated, represents over 50% of the groups overall operating profit), Entertainment One acts as a third-party distributor for producers that lack the size to facilitate their own world-wide distribution. Think smaller indie films rather than your Avatars and Titanics.

After a detailed screening process, Entertainment One takes on the role of distributor for those selected titles, utilising their operations in North America and Europe.

In exchange for distribution and fronting production cash, Entertainment One receives a percentage of the film’s rights. This tends to include not only the cinema takings, but TV, DVD and digital rights into the future.

Add to the film arm a smaller record label and a burgeoning television business (with the income potential from intellectual property rights that childrens television in particular throws up) and a healthy history of geographical diversity through acquisition and Entertainment One gives off all the right vibes of an entertainment company on the move.

Which brings us neatly to the over-riding reasoning behind our decision to take a little dip in the Entertainment One pool. Although currently trading on AIM, Entertainment One has Full List aspirations.

So yep, we jumped in, taking up 2,267 of these little beauties at £0.61 a pop for a total outlay of £1,382.87 before costs on 11th May 2010.

As always my ramblings are those of an amateur and should never be viewed as investment advice. Always do plenty of your own research and get your information from a variety of sources. Thanks again for dropping by.

There are one or two potential purchases we’ll be looking closely at in the coming days using the stockpile of cash we’re sitting on after our West China Cement sale, so stay tuned. And don’t worry too much about that conservative edge, I’m working on ridding it as a bit of a priority.

Our brief love affair – this time around, for we have loved before – began in July 2009 when I picked up 153 of these little grey beauties at £1.70. Watching our love take flight, two short weeks later I added another 221 shares at an already soaring £2.57. My 374 shares were averaged in at £2.21, for a total outlay of £828.21 before costs. Ahhh, the early days of a relationship.

At the dawn of our wonderful time together West China Cement surged through £3 before flitting around £4 for a spell. She then busted through £5, then £6 and briefly flirted with £7. What a beauty!

With a rendezvous with the Hong Kong board on the horizon, I was confident when we met, that her price would be heading in one direction, and one direction only. And WCC.L didn’t let me down. Could it be that I could be holding a five-bagger, hell, even a ten-bagger. Did this tryst have no bounds?

Then the dreaded ‘Dear John’ email from my broker. I’ll cut to the chase……..”we are unable to trade equities on the Hong Kong board”. Heartbreak!

Now it was at this time I had a decision to make. Transfer the shares to another broker – a broker that traded in Hong Kong securities, a broker alas, I did not have – and continue our fling or remember the beautiful times we had together and go searching for other AIM runaways.

I choose the later and I’ll tell you why.

It’s not everyday you land a triple-bagger in ten months – I sold out at £6.60 on the 4th May for a total return of £2,468.40, a profit of £1,640.19 on top of an £828.21 investment.

Moreover, the situation in Greece had kicked in and although I had faith that it would be resolved (patched up) quickly, confidence in the markets for weeks even months following is bound to be dented. A pound had already been knocked off WCC’s recent highs. And at the end of the day we had loved before and chances are we will love again.

Alfred Lord Tennyson put it best when he said, “it is better to have loved and lost than never to have loved at all“. And chances are he hadn’t just cashed in on a triple-bagger.

Now I’m off to open an account with a broker that allows me to trade in Hong Kong. Remember to do a ton of your own research and thanks again for dropping by.

Now hindsight is a wonderful thing, but when Renesola topped out at a little over £2.50 last week, my finger hovered over the sell button. It hovered but nothing more. It was the run-up to results (due out on May 10th if I’m not mistaken) and often that lead up to an expected good set of results sees the price peak. Then, when the results are confirmed the market has already factored in their healthy goodness and share prices can actually retreat a little. Now, Renesola has been bouncing along between 75 and 225 pence for the past 18 months, so when it breaks those levels I tend to take a bit of a closer look. Hence the finger hover.

Enter the Greece situation and markets across the board stall, despite what they were doing two to three weeks back. What was positive sentiment in the lead up to a results date (in the case of Renesola) has been influenced by macro trends where investors are playing a cautious hand and hanging off on further commitments at best and often liquidating some or all of their portfolios at worst.

In the end I held onto my Renesola. I’m still not confident it was the right thing to do but looking at my portfolio as it stands today, Renesola is battling on – it’s the only splash of blue in a sea of red. Time will tell whether that hover should have been hard click.

As it panned out we were pretty quick on the draw, picking up 1,598 shares at 66 pence a share for a total outlay of £1,054.68 after selling off our remaining Eros International holdings and a little Renesola last Thursday.

We see a massive potential for growth with OPG and following a dip from their 90+ pence high late last year, now seemed as good a time as any to take the plunge.

For those of you that have followed Investor Trader over the journey you’ll know that we often buy and sell a little Renesola on the dips and peaks.

And although we believe Rensola’s current surge toward £2 still has a ways to travel, we sold 292 shares for £1.90 for a total return of £554.40.

We were averaged into Renesola at £1.12, so our 292 shares netted a total profit of £227.76 and we’re still holding 1,400 into the bargain.

We settled on liduidating the remaining tranche of our EROS International holdings for no better reason than we needed the dinero.

We were averaged into Eros International (EROS.L) at 105 pence and sold out at 165 pence turning a £180 profit on the final 300 shares we held.

We’ll be keeping an eye on Eros with the view of buying back on a dip if the opportunity arises.